RE:RE:RE:RE:RE:RE:AUA Poster SessionThanks Eog, I assumed it was older data but you never know. I also assume they would have the most recent data for their presentation.
This field is always high risk/reward but after all this time I would like to think the risk has been lessened significantly. Given that they have frequent communication with the FDA and when they do talk they seem pretty confident it would seem that the trading activity is intended to make some people nervous. People are selling what they feel comfortable selling in the near term but the sell side is pretty thin behind that.
Let's hope we get some clarification by early May, bladder cancer month.
Yajne wrote: Saw that too SB. IMO this can't be the recent data with lower number of evaluable patients.
Hopefully, they will present the latest updated numbers at the AUA.
This is now looking much more like a high risk/reward 'binary' play...it's either 'on' or 'off' with the FDA decision looming. In the absence of communication, I've assumed they have applied for BTD at this point, but IMO we're completely in a vacuum of info at the moment.